8th from bottom: Hospira, down 45.47%
Takeover talk is swirling around the Lake Forest drugmaker as the Abbott Laboratories spinoff works through regulatory concerns.
Copyright
© 2017, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad